Behind every psychoanalyst stands the man with the syringe, said Freud. Last week, at the annual meeting of the American Psychiatric Association in Chicago, the syringe-wielders held the spotlight. The momentous goal toward which they were advancing: chemical treatment of schizophrenia and other mental disorders.
Attention centered first on Dr. Stig Akerfeldt, a boyish (27), blond biochemist from Stockholm's famed Nobel Institute, who had reported that when a certain chemical is added to a sample of blood serum, it will turn a bright red if the subject has schizophrenia or other severe mental illness. Akerfeldt's method has been touted as a "test"...
To continue reading:
or
Log-In
